Phase II study of pirarubicin in advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Phase II study of pirarubicin in advanced non-small cell lung cancer

Published:1989-10 Issue:10 Volume:25 Page:1507-1508
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Berthaud Patrice,Le Chevalier Thierry,Berille Jocelyne,Herait Patrice,Baldeyrou Pierre,Tursz Thomas,Arriagada Rodrigo,Spielmann Marc,Hayat Marcel

Publisher

Elsevier BV

Subject

Oncology

Reference7 articles.

1. Tetrahydropyranyl derivatives of daunomycin and Adriamycin®;Umezawa;J Antibiot Tokyo,1979

2. 4′-O-Tetrahydropyranyl-adriamycin as a potential new antitumor agent;Tsuruo;Cancer Res,1982

3. Comparative experimental studies on 4′-O-tetrahydropyranyl-adriamycin and Adriamycin®;Umezawa,1983

4. Comparative experimental study and evaluation of the degree of cardiotoxicity and alopecia of twelve different anthracyclines using the golden hamster model;Dantchev,1983

5. An oriented phase II trial of THP-Adriamycin® in breast carcinoma;Mathe;Biomed Pharmacother,1986

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer;Journal of Cancer Research and Clinical Oncology;1994-03

2. Highly sensitive method for the determination of a new anthracycline: Pirarubicin;Chromatographia;1993-04

3. Response rate as criterium to evaluate chemotherapy in non-small cell lung cancer;Lung Cancer;1991-04

4. Chemotherapy in advanced non-small cell lung cancer;European Journal of Cancer and Clinical Oncology;1990-01